欧盟评估乳酸肠球菌DSM 10663作为育肥鸡、育肥火鸡等物种饲料添加剂的授权更新申请

核心提示：2026年3月3日，欧盟食品安全局（EFSA）发布消息，欧盟食品安全局（EFSA）发布关于乳酸肠球菌DSM 10663作为饲养小牛、小猪、育肥鸡、育肥火鸡、猫和狗饲料添加剂的授权更新申请的评估。……（世界食品网-www.shijieshipin.com）

　　 2026年3月3日，欧盟食品安全局（EFSA）发布消息，欧盟食品安全局（EFSA）发布关于乳酸肠球菌DSM 10663作为饲养小牛、小猪、育肥鸡、育肥火鸡、猫和狗饲料添加剂的授权更新申请的评估。
　　经过评估，专家小组得出结论，该添加剂在授权使用条件下对目标物种、消费者和环境都是安全的。在授权更新的情况下，无需评估添加剂的功效。部分原文报道如下：

　　Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of the additive Oralin®, a preparation containing viable cells of Enterococcus lactis DSM 10663 (formerly identified as Enterococcus faecium), as a zootechnical feed additive for calves for rearing, piglets, chickens for fattening, turkeys for fattening, cats and dogs. The applicant has provided evidence that the additive currently in the market complies with the existing conditions of authorisation. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the additive remains safe for the target animals, consumers and the environment under the authorised conditions of use. Regarding user safety, the additive in all forms should be considered as a skin and respiratory sensitiser. Exposure by dermal and respiratory routes is considered a risk. The additive is not irritant to eyes in the powder (Oralin® 350 P), granulated (Oralin® 350 G) and liquid (Oralin® 100 S) preparations. The FEEDAP Panel is not in the position to conclude on the irritancy potential for eyes of the coated form (Oralin® 200 C). There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.